 This included working to commercialize a DNA-based therapeutic compound as a potential treatment for ovarian cancer.Foligo Therapeutics later folded due to lack of funds.Subsequently, Jhaveri founded Sound Affects, a non-profit organization dedicated to "changing how the war on cancer is fought and financed."